{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:08:30Z","timestamp":1789654110351,"version":"4.0.0"},"reference-count":32,"publisher":"Medknow","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijd.ijd_703_16","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T02:22:41Z","timestamp":1511490161000},"page":"510","source":"Crossref","is-referenced-by-count":16,"title":["Cutaneous adverse drug reactions in a tertiary care teaching hospital in India: An intensive monitoring study"],"prefix":"10.4103","volume":"62","author":[{"given":"Sejal","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TejasK","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Vahora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Bhabhor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raksha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0019-5154.219231-1","first-page":"839","volume-title":"Cutaneous reactions to drugs.An analysis of spontaneous reports in four Italian regions","author":"Naldi","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0019-5154.219231-2","first-page":"357","volume-title":"Cutaneous drug reactions","author":"Svensson","year":"2001","journal-title":"Pharmacol Rev"},{"key":"key-10.4103\/0019-5154.219231-3","first-page":"20","volume-title":"Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care center in South India","author":"Pudukadan","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-4","first-page":"S76","volume-title":"Cutaneous adverse drug reactions in Indian population: A systematic review","author":"Patel","year":"2014","journal-title":"Indian Dermatol Online J","ISSN":"https:\/\/id.crossref.org\/issn\/2229-5178","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-5","first-page":"227","volume-title":"Cutaneous drug reactions in patients admitted to the dermatology unit at the university hospital of the West Indies, Kingston, Jamaica","author":"East-Innis","year":"2009","journal-title":"West Indian Med J"},{"key":"key-10.4103\/0019-5154.219231-6","first-page":"834","volume-title":"Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia","author":"Ding","year":"2010","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0019-5154.219231-7","first-page":"95","volume-title":"Cutaneous adverse drug reactions: Clinical pattern and causative agents \u2013 A 6 year series from Chandigarh, India","author":"Sharma","year":"2001","journal-title":"J Postgrad Med","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3859","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-8","unstructured":"Mann RD, Andrews EB, editors. Introdution. In: Pharmacovigilance. 2nd ed. England: John Wiley & Sons, Ltd.; 2007. p. 3-11."},{"key":"key-10.4103\/0019-5154.219231-9","first-page":"1255","volume-title":"Adverse drug reactions: Definitions, diagnosis, and management","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"key-10.4103\/0019-5154.219231-10","unstructured":"ATC\/DDD Index 2016. WHO Collaborating Centre for Drug Statistics Methodology. WHO Collaborating Centre, Oslo, Norway. Available from: http:\/\/www.whocc.no\/atc_ddd_index\/. [Last accessed on 2016 Nov 25]."},{"key":"key-10.4103\/0019-5154.219231-11","unstructured":"The Uppsala Monitoring Centre. The Use of the WHO-UMC System for Standardised Case Causality Assessment. Available from: http:\/\/www.who-umc.org\/Graphics\/24734.pdf. [Last accessed on 2016 May 15]."},{"key":"key-10.4103\/0019-5154.219231-12","first-page":"303","volume-title":"Comment: Hospital admissions resulting from preventable adverse drug reactions","author":"Lau","year":"2003","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0019-5154.219231-13","unstructured":"ICH E2A Guideline: Note for Guidance on Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf. [Last accessed on 2016 May 15]."},{"key":"key-10.4103\/0019-5154.219231-14","unstructured":"ICH E11 Guideline: Clinical Investigation of Medicinal Products in the Pediatric Population. Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E11\/Step4\/E11_Guideline.pdf. [Last accessed on 2017 08]."},{"key":"key-10.4103\/0019-5154.219231-15","unstructured":"ICH E7 (R1) Guideline: Studies in Support of Special Populations: Geriatrics. Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E7\/Q_As\/E7R1_Final_Concept_Paper.pdf. [Last accessed on 2017 Aug 08]."},{"key":"key-10.4103\/0019-5154.219231-16","first-page":"50","volume-title":"Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective","author":"Nandha","year":"2011","journal-title":"Int J Appl Basic Med Res"},{"key":"key-10.4103\/0019-5154.219231-17","first-page":"430","volume-title":"Clinical study of cutaneous drug eruptions in 200 patients","author":"Patel","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-18","first-page":"168","volume-title":"A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India","author":"Sharma","year":"2015","journal-title":"Indian Dermatol Online J","ISSN":"https:\/\/id.crossref.org\/issn\/2229-5178","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-19","first-page":"523","volume-title":"Cutaneous adverse drug reactions seen at a university hospital department of dermatology","author":"Borch","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0019-5154.219231-20","first-page":"46","volume-title":"Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies","author":"Beijer","year":"2002","journal-title":"Pharm World Sci"},{"key":"key-10.4103\/0019-5154.219231-21","first-page":"1139","volume-title":"Frequency of adverse drug reactions in hospitalized patients: A systematic review and meta-analysis","author":"Miguel","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.4103\/0019-5154.219231-22","first-page":"734","volume-title":"An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia","author":"Choon","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-23","first-page":"102","volume-title":"Severe cutaneous adverse drug reactions: A clinicoepidemiological study","author":"Sasidharanpillai","year":"2015","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-24","first-page":"1018","volume-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","author":"Fiszenson-Albala","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.219231-25","first-page":"83","volume-title":"Factors affecting the development of adverse drug reactions (Review article)","author":"Alomar","year":"2014","journal-title":"Saudi Pharm J"},{"key":"key-10.4103\/0019-5154.219231-26","first-page":"128","volume-title":"Incidence of adverse drug reactions in Indian hospitals: A Systematic review of prospective studies","author":"Patel","year":"2016","journal-title":"Curr Drug Saf"},{"key":"key-10.4103\/0019-5154.219231-27","first-page":"15","volume-title":"Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India","author":"Jhaveri","year":"2014","journal-title":"J Pharmacol Pharmacother","ISSN":"https:\/\/id.crossref.org\/issn\/0976-500X","issn-type":"print"},{"key":"key-10.4103\/0019-5154.219231-28","first-page":"143","volume-title":"Observation of drug utilization pattern and prevalence of diseases in elderly patients through home medication review","author":"Upadhyay","year":"2011","journal-title":"Asian J Pharm Clin Res"},{"key":"key-10.4103\/0019-5154.219231-29","first-page":"517","volume-title":"Analysis of cutaneous adverse drug reactions at a tertiary care hospital \u2013 A prospective study","author":"Shah","year":"2011","journal-title":"Trop J Pharm Res"},{"key":"key-10.4103\/0019-5154.219231-30","first-page":"461","volume-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","author":"Brahimi","year":"2010","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0019-5154.219231-31","first-page":"471","volume-title":"Severe cutaneous adverse reactions to drugs \u2013 Relevant aspects to diagnosis and treatment \u2013 Part I: Anaphylaxis and anaphylactoid reactions, erythroderma and the clinical spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's disease)","author":"Criado","year":"2004","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0019-5154.219231-32","first-page":"2","volume-title":"Adverse cutaneous drug reaction","author":"Nayak","year":"2008","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T02:23:52Z","timestamp":1511490232000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.e-ijd.org\/text.asp?2017\/62\/6\/510\/219231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"alternative-id":["219231"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_703_16","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}